Clinical Trial Update: Clinical Trial to Evaluate Efficacy and Safety of DP-R202 and Anplag in Patients With Artery Occlusive Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating DP-R202 and Anplag for peripheral arterial disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Anplag
• DP-R202 (DP-R202)

Snippet

Sponsor: Alvogen Korea | Conditions: Peripheral Arterial Disease | Phase 3 | Status: COMPLETED